Ozempic’s popularity leads to shortages for people with Type 2 diabetes

(By Sydney Lupkin for NPR)

Jim Cox had heard of people with Type 2 diabetes who were unable to get Ozempic because the drug was being used off-label for weight loss. He just didn’t think the shortage would affect him.

He has the disease too, but he takes a different drug called Trulicity, which is in the same class of GLP-1 drugs as Ozempic. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.